HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shengjin Li Selected Research

Shengjin Li Research Topics

Disease

8Neoplasms (Cancer)
01/2022 - 09/2006
2Carcinoma (Carcinomatosis)
01/2022 - 02/2009
2Cholangiocarcinoma
07/2010 - 12/2009
2Shock
09/2008 - 03/2007
2Neoplasm Metastasis (Metastasis)
04/2008 - 02/2008
2Papillary Thyroid Cancer
02/2008 - 09/2006
2Rectal Neoplasms (Rectal Cancer)
09/2006 - 07/2006
1Adenocarcinoma of Lung
01/2022
1Inflammation (Inflammations)
01/2019
1Asthma (Bronchial Asthma)
01/2019
1Squamous Cell Carcinoma of Head and Neck
03/2011
1Stomach Neoplasms (Stomach Cancer)
02/2009
1Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2009
1Carcinoid Tumor (Carcinoid)
02/2009
1Septic Shock (Toxic Shock Syndrome)
09/2008
1Sepsis (Septicemia)
09/2008
1Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2008
1Hyperplasia
02/2008
1Adenoma (Adenomas)
02/2008

Drug/Important Bio-Agent (IBA)

3Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
07/2010 - 02/2009
3Monoclonal AntibodiesIBA
07/2010 - 04/2008
2AntigensIBA
07/2010 - 02/2008
2EndotoxinsIBA
09/2008 - 03/2007
2ParaffinIBA
04/2008 - 09/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2008 - 09/2006
2ErbB Receptors (EGF Receptor)IBA
09/2006 - 07/2006
1Therapeutic UsesIBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1OvalbuminIBA
01/2019
1CurcuminIBA
01/2019
1Carrier Proteins (Binding Protein)IBA
03/2011
1Insulin-Like Growth Factor II (Somatomedin A)IBA
03/2011
1CarcinogensIBA
03/2011
1Messenger RNA (mRNA)IBA
03/2011
1Biomarkers (Surrogate Marker)IBA
03/2011
1Small Interfering RNA (siRNA)IBA
07/2010
1Chemokine ReceptorsIBA
02/2009
1Proteins (Proteins, Gene)FDA Link
02/2009
1LigandsIBA
09/2008
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
09/2008
1CytokinesIBA
09/2008
1Toll-Like Receptors (Toll-Like Receptor)IBA
09/2008
120- O- (beta- D- glucopyranosyl)- 20(S)- protopanaxadiolIBA
09/2008
1Formaldehyde (Formol)FDA Link
04/2008
1Histocompatibility Antigens Class IIIBA
02/2008
1MHC class II transactivator proteinIBA
02/2008
1HLA-DR Antigens (HLA-DR)IBA
02/2008
1Phosphotransferases (Kinase)IBA
02/2008
1HLA-DQ Antigens (HLA-DQ)IBA
02/2008
1PeroxiredoxinsIBA
03/2007
1Galectin 3 (LGALS3)IBA
09/2006
1Cyclin D1IBA
09/2006
1Capecitabine (Xeloda)FDA Link
09/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2006

Therapy/Procedure

2Therapeutics
07/2010 - 09/2008
1Radiotherapy
04/2008
1Intravenous Injections
03/2007
1Chemoradiotherapy
09/2006
1Drug Therapy (Chemotherapy)
09/2006